ReviewThe journal of prevention of Alzheimer's disease2026

A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer's disease.

Tianle Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.